6. Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, Grobbee DE, et al. Eff ects of fi brates on cardiovascular outcomes: a systematic

in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849–61. 5. Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, et al. Effects of combination lipid therapy in type 2 diabetes

Ayşe Naciye ERBAKAN, Aytekin OĞUZ

Dergi: Türk Kardiyoloji Derneği Arşivi
Sayı: 2017 · Cilt: 45 - Sayı: Suppl. 1 (Özel Sayı)
Sayfa: 36–39
DOI: —

Özet

Anti-apoptotik ??AMP aktive protein kinaz ?/AMP aktive protein kinaz Endotel kaynaklı nitrik oksit sentaz ? IGF1R yaşam sinyalizasyonu ?Endotel hücre apoptozu hücre apoptozu ?Retinal pigment epitel

Abstract

9. Sacks FM, Carey VJ, Fruchart JC. Combination lipid therapy in type 2 diabetes. N Engl J Med 2010;363:692–4. 10. Lee M, Saver JL, Towfighi A, Chow J, Ovbiagele B. Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic